Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Trading Update

12 Dec 2014 15:00

RNS Number : 6804Z
Sopheon PLC
12 December 2014
 

SOPHEON PLC

("Sopheon" or the "Company")

 

TRADING UPDATE

 

Sopheon plc ("Sopheon"), the international provider of software and services that improve the return from innovation and new product development investments, issues a trading update.

 

We have previously highlighted that we expected performance in 2014 to be weighted to the back end of the year, consistent with the fourth quarter of 2013 which was the strongest in our history. Full year revenue visibility today stands at $17.4m compared to $15.0m at the time of the interims. Once again, meeting our commercial goals required a strong finish to the year, and our pipeline included several major license opportunities that would contribute to achieving them. As we approach the end of the year, orders are coming through, and this includes a record number of signatures expected from new customers, expanding our traditionally strong base of existing customers and underpinning future growth potential. However, it now looks increasingly likely that a number of the highest value orders will defer into the first quarter of 2015. As a result, revenue and profits for 2014 will fall below market expectations. As in previous years we will update shareholders on the year's actual performance in January. As we have often stated, the nature of our business makes it difficult to predict exactly when sales will get signed and be recognized. .

 

Since our interim statement, we have continued to push forward with operational and corporate developments. We released version 9.2 of our Accolade solution suite, which we believe provides the most comprehensive resource and portfolio planning and management capabilities in the market. We were delighted to hire Pieter Leijten, a senior business development director formerly at Infor. Pieter has a solid track record of overachievement in enterprise software sales and will lead our commercial team in Europe.

 

Since 2012 Sopheon has implemented a series of actions to improve its corporate profile. These include transferring our Amsterdam listing from Euronext to Alternext; a share consolidation to reduce both the number of shares in issue and the very large number of very small shareholders; a capital restructuring to substantively reduce accumulated losses on the balance sheet; and the securing of new facilities with Silicon Valley Bank. As previously announced, we have faced some challenges. Following our transfer, Euronext announced the closure of Alternext Amsterdam by the end of 2015; the board has not yet concluded on the most appropriate path to address this change. In addition, processing issues in the Netherlands that arose during the original share consolidation procedure led us to initiate a new procedure in recent weeks. The first step, a 500:1 consolidation, was implemented on 18 October and the shareholder meeting for the second step, a 1:500 subdivision, is scheduled for 19 December. Following the first step the directors made a number of share purchases, in Amsterdam, with the intention of providing support for the fractional entitlements that became available, and also underlining the board's continued confidence in the business.

 

A definition of how visibility is calculated was provided in our half- yearly report published on 28 August 2014. 

 

For further information contact:

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7220 0500

Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange, and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZLLFFZLFZFBV
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.